MedTrace Logo

Cimarrón Bean Extrudate Solution on Platelet Function and Biochemical Parameters

NCT07043829 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-04-09

Study results available
· View outcomes & findings →

Summary

This non-randomized acute clinical trial evaluates the effect of consuming a water-based solution of Cimarrón bean extrudate on platelet function and postprandial glycemia in adults.

Participants will consume a single 10-gram dose of Cimarrón bean extrudate dissolved in water. Blood samples will be collected before and after the intervention to assess platelet reactivity using flow cytometry and to measure glucose levels through colorimetric spectrophotometry. The total intervention period will last approximately 8 hours. This study aims to explore whether the acute consumption of this legume-based functional product can influence hemostatic and glycemic responses in the postprandial state.

Conditions

  • Postprandial Glucose
  • Platelet Activation

Interventions

DIETARY_SUPPLEMENT

SPVCE (Solution Phaseolus vulgaris L. var. Cimarrón Extrudate in Water)

A single oral dose of 10 grams of Cimarrón bean (Phaseolus vulgaris L., variety Cimarrón) extrudate dissolved in 500 mL of water, consumed once under fasting conditions, to evaluate acute effects on platelet function (reactivity and blood risk), postprandial glycemia, and total polyphenol concentration at baseline (0 hours), 2 hours, and 6 hours after SPVCE consumption.

Sponsors & Collaborators

  • Centro de Estudios en Alimentos Procesados

    collaborator OTHER

  • University of Talca

    lead OTHER

Principal Investigators

  • Ivan F Palomo Gonzalez, PhD. Biomedical Science · University of Talca

  • Eduardo J Fuentes Quinteros, PhD. Science research · University of Talca

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-13
Primary Completion
2025-06-19
Completion
2025-06-19

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07043829 on ClinicalTrials.gov